TY  - JOUR
T1  - The future of obesity treatment: Comment on “integrating technology into standard weight loss treatment: a randomized controlled trial”
AU  - Rao G, Kirley K
Y1  - 2013/01/28
N1  - 10.1001/jamainternmed.2013.1232
JO  - JAMA Internal Medicine
SP  - 111
EP  - 112
VL  - 173
IS  - 2
N2  - 
A staggering 68% of US adults are either overweight or obese.1 Current direct medical costs associated with treating obesity-related illness are roughly 5% to 10% of all US health care spending.2 Effective solutions to this epidemic are scarce, expensive, or both. The mean cost of bariatric surgery is $27 905.3 Few medications are available for weight loss, and despite recent promising developments, obesity drugs are unlikely to become a solution to the problem.4 Many believe significant changes in public policy and the built environment will be necessary to reverse the epidemic.5- 6 Such changes require a great deal of political will, which is lacking, and in any case would take many years to have a significant effect. So, what on earth should we do right now or in the near future?

SN  - 2168-6106
M3  - doi: 10.1001/jamainternmed.2013.1232
UR  - http://dx.doi.org/10.1001/jamainternmed.2013.1232
ER  -